Dadun/></a>
				</td>
				<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Oncología > Biomarcadores > DA - CIMA - Oncología - Biomarcadores - Artículos de Revista >

Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations
Authors: Field, J.K. (J. K.)
Brambilla, C. (C.)
Caporaso, N.E. (Neil E.)
Flahault, A. (A.)
Henschke, C.I. (C. I.)
Herman, J. (J.)
Hirsch, F. (F.)
Lachmann, P. (P.)
Lam, S. (S.)
Maier, S. (S.)
Montuenga, L.M. (Luis M.)
Mulshine, J.L. (James L.)
Murphy, M. (Murphy)
Pullen, J. (J.)
Spitz, M. (M.)
Tockman, M. (M.)
Tyndale, R. (R.)
Wistuba, I.I. (Ignacio I.)
Youngson, J. (J.)
Keywords: Lung cancer
Consensus statement
Workshop report
Spiral CT
Molecular biomarkers
Sputum
Validation
Ethics
Issue Date: 2002
Publisher: Spandidos Publications
Publisher version: http://www.spandidos-publications.com/ijo/21/2/369
ISSN: 1791-2423
Citation: Field JK, Brambilla C, Caporaso N, Flahault A, Henschke C, Herman J, et al. Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations. Int J Oncol 2002 Aug;21(2):369-373.
Abstract
The Second Molecular Biomarkers Workshop was held at the Roy Castle International Centre for Lung Cancer Research in Liverpool, in June 2001 and it brought together experts in the clinical, epidemiological and molecular-pathology of lung cancer from Europe and the USA, to address issues surrounding the development of a European strategy for early lung cancer detection. The 2001 Workshop Breakout Groups concentrated on the current challenges in the early detection of lung cancer which need to be addressed in the light of the recent surge in interest in many countries for mounting new clinical trials to evaluate the utility of Spiral CT in early lung cancer detection. If population-based trials of CT screening are mounted it will also be a favorable clinical environment in which to evaluate efficiently recent advances in molecular screening and genotyping. The Workshop focused specifically on: a) clinical and molecular biomarkers, b) sputum as an early detection and diagnostic tool, c) validation of molecular markers prior to their use in early detection trials and d) ethical issues that have to be considered in early lung cancer detection trials. A distillation of the Workshop discussions is given in this article.
Permanent link: http://hdl.handle.net/10171/20184
Appears in Collections:DA - Ciencias - HAP - Artículos de revista
DA - CIMA - Oncología - Biomarcadores - Artículos de Revista

Files in This Item:
File:  31Field et al_IntJOncol02.pdf
Description: 
Size:  634,56 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.